Endocrine Therapies in ER-Positive/HER2-Negative MBC: Understanding Their Benefits and Limitations to Optimize Treatment Selection Authors: Joyce A. O’Shaughnessy, MD; Aditya Bardia, MD, MPH, FASCO

https://www.medscape.org/viewarticle/1003008?sso=true&impID=7807787&uac=148436CN&src=wnl_tpal_251018_mscpedu